Daily BriefsMost Read

Most Read: Seven & I Holdings, Hang Seng Index, Sumitomo Corp, Horizon Robotics, BeiGene , ZhongAn Online P&C Insurance C, Mayne Pharma and more

In today’s briefing:

  • 7&I (3382) – Bain Gets York Holdings with a Surprising Price, And We Approach Deal Deadlines
  • Hang Seng Internet & IT Index Rebalance: Five Changes with First De-SPAC Listing In
  • Hang Seng Index (HSI) Rebalance: Does Anyone Know What the Index Committee Is Thinking?
  • Warren Buffett and the Japanese Trading Houses I
  • HSCI Index Rebalance: 29 Adds, 41 Deletes & Changes to Southbound Stock Connect
  • HSCEI Index Rebalance: Beigene, ZTO Replace Sino Biopharma, Li Ning; Surprise for Some
  • HSTECH Index Rebalance: Horizon Robotics, Tencent Music Replace East Buy, ZA Online; US$2.3bn Trade
  • Mayne Pharma (MYX AU): Cosette Pharma’s Binding Offer at A$7.40
  • Merger Arb Mondays (24 Feb) – Seven & I, Proto, Tam Jai, Pentamaster, Vesync, Canvest, Domain
  • Seven & I Restructures but Discontent Rises Among Franchisees and Customers


7&I (3382) – Bain Gets York Holdings with a Surprising Price, And We Approach Deal Deadlines

By Travis Lundy

  • Over the weekend, the Nikkei and Jiji reported the 7&i Board met Saturday and decided Bain would have preferred negotiating rights to buy York Holdings. They bid “over ¥700bn.”
  • That’s a trifle lower than the ¥1.2trn Reuters reported (on Christmas Day) Bain bid but details aren’t known. Proper structuring would get the vast majority to 7&i in post-tax cash.
  • For 7&i to decide by the AGM (which could be contentious), they need time to debate. Bids are likely needed in 3wks. In the meantime, “Trump Risk” lurks.

Hang Seng Internet & IT Index Rebalance: Five Changes with First De-SPAC Listing In

By Brian Freitas

  • There will be 5 changes for the Hang Seng Internet & Information Technology Index (HSIII Index) at the March rebalance. There is one surprise for us with Synagistics being added.
  • Estimated one-way turnover at the rebalance is 6.5% resulting in a round-trip trade of HK$3.74bn (US$482m). 4 stocks will have over 1x ADV to trade.
  • Horizon Robotics (9660 HK) is an add to the HSIII, Hang Seng TECH Index and HSCI. Inclusion in Southbound Stock Connect will take place in May.

Hang Seng Index (HSI) Rebalance: Does Anyone Know What the Index Committee Is Thinking?

By Brian Freitas

  • We continue to be led down the garden path – no constituent changes for the Hang Seng Index (HSI INDEX) in March means we remain at 83 members.
  • Despite having an opportunity to add stocks to the index without increasing turnover, the index committee have done nothing. Which begs the question – what exactly are they waiting for?
  • Float and capping changes result in an estimated one-way turnover of 3.8% and the resulting round-trip trade is HK$16.7bn (US$2.15bn).

Warren Buffett and the Japanese Trading Houses I

By Travis Lundy

  • The Berkshire Hathaway Annual Shareholder Letter for 2024 was released this weekend. Much was made in Japanese twitter-space of the comments he made on the Japanese trading houses. 
  • He said Berkshire Hathaway’s admiration of these companies “has consistently grown” and Berkshire likes their capital deployment, managements, and their attitude in respect to investors. They also pay themselves reasonably.
  • He mentioned Berkshire will increase their stakes somewhat in the trading houses “over time.” That comment deserves some exploration, as does the comment about yen funding.

HSCI Index Rebalance: 29 Adds, 41 Deletes & Changes to Southbound Stock Connect

By Brian Freitas

  • There are 29 adds and 41 deletes for the Hang Seng Composite Index (HSCI) at the March rebalance to take the number of index constituents down to 505.
  • We expect 27 of the 29 HSCI inclusions to be added to Stock Connect from the open on 10 March while Horizon Robotics (9660 HK) should be added in May.
  • We expect 28 of the 41 HSCI deletions will be removed from Stock Connect and there has been increased Southbound holding in a lot of the stock this calendar year.

HSCEI Index Rebalance: Beigene, ZTO Replace Sino Biopharma, Li Ning; Surprise for Some

By Brian Freitas



Mayne Pharma (MYX AU): Cosette Pharma’s Binding Offer at A$7.40

By Arun George

  • Mayne Pharma (MYX AU) entered a scheme implementation deed with Cosette Pharma at A$7.40 per share, a 36.8% premium to the undisturbed price.
  • The offer is conditional on shareholder and FIRB approval. The vote is low-risk as the two largest shareholders are supportive.  
  • The offer is reasonable but not a knockout bid. At the last close and for an end-of-May payment, the gross/annualised spread was 2.8%/11.0%. 


Seven & I Restructures but Discontent Rises Among Franchisees and Customers

By Michael Causton

  • York HD is due to take over operation of all group business except Seven Eleven at the end of February and press reports suggest Bain’s bid has been accepted.
  • All of which is fine but this leaves Seven Eleven Japan which is struggling against rivals. Even franchise owners are becoming more critical.
  • A recent survey by Nikkei also suggested that consumers are increasingly favouring Lawson and Familymart and 30% visited Seven Eleven stores less frequently in 2024. This is a big problem.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars